The Leadership Team at Memo Therapeutics drives strategic decision-making and oversees the development of cutting-edge antibody discovery initiatives. Comprising key executives like the Chief Science Officer, Senior Vice President of Development, Chief Medical Officer, and Vice President of Clinical Operations, this team ensures alignment between research, clinical development, and business objectives to propel the company’s innovative therapies forward.
View all